A rare gastric lesion: diminutive, well-differentiated, Grade 3, type 3 gastric neuroendocrine tumor with extremely high ki-67 index removed en bloc under endoscopy

[1]  R. Coriat,et al.  Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions , 2021, Cancers.

[2]  T. Sano,et al.  Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[3]  T. Halfdanarson,et al.  Management of Well-Differentiated High-Grade (G3) Neuroendocrine Tumors , 2019, Current Treatment Options in Oncology.

[4]  F. Rodrigues,et al.  Gastric neuroendocrine neoplasm with late liver metastasis , 2018, Endocrinology, diabetes & metabolism case reports.

[5]  P. Ruszniewski,et al.  Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement. , 2016, The oncologist.

[6]  A. Vanoli,et al.  The Clinicopathologic Heterogeneity of Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms: Morphological Differentiation and Proliferation Identify Different Prognostic Categories , 2016, Neuroendocrinology.

[7]  P. Ruszniewski,et al.  ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms , 2016, Neuroendocrinology.

[8]  C. Chougnet,et al.  Characteristics and treatment of patients with G3 gastroenteropancreatic neuroendocrine neoplasms. , 2015, Endocrine-related cancer.

[9]  A. Krasinskas,et al.  The High-grade (WHO G3) Pancreatic Neuroendocrine Tumor Category Is Morphologically and Biologically Heterogenous and Includes Both Well Differentiated and Poorly Differentiated Neoplasms , 2015, The American journal of surgical pathology.

[10]  A. Vanoli,et al.  Gastric neuroendocrine neoplasms and related precursor lesions , 2014, Journal of Clinical Pathology.

[11]  Y. Ajioka,et al.  Mucin phenotype expression of gastric neuroendocrine neoplasms: analysis of histopathology and carcinogenesis , 2014, Gastric Cancer.

[12]  K. Choi,et al.  Long-term follow up of endoscopic resection for type 3 gastric NET. , 2013, World journal of gastroenterology.

[13]  C. Lepage,et al.  Well-differentiated grade 3 digestive neuroendocrine tumors: Myth or reality? The PRONET study group. , 2012 .

[14]  L. Grimelius,et al.  Gastric Carcinoids: Biologic Behavior and Prognosis After Differentiated Treatment in Relation to Type , 2005, Annals of surgery.

[15]  H. Sorbye,et al.  Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[16]  M. Terashima,et al.  A Case of Recurrence as Lymph Node Metastasis Ten Years after Endoscopic Resection for Minute Gastric Carcinoid , 2011 .